Target Oncol. 2017 Aug 11;:
Clin Lung Cancer. 2017 Jan 05;:
Clin Lung Cancer. 2016 Oct 26;:
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.
Ann Oncol. 2016 Oct 11;:
Curr Oncol. 2016 Aug;23(4):e435
176P: ALK-rearranged non-small cell lung cancer is associated with a high rate of venous thromboembolism.
J Thorac Oncol. 2016 Apr;11(4 Suppl):S134
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers.
Curr Oncol. 2016 Feb;23(1):52-5
Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients.
Br J Cancer. 2016 Feb 18;
Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2015 Dec 21;